Analysts provide stock recommendations for Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed the day trading at $9.97 down -1.97% from the previous closing price of $10.17. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 5185801 shares were traded. Ratios: For a better understanding of RXRX, let’s look at its different ratios. For […]

Recursion Pharmaceuticals Inc (RXRX) Rise 4.08% in Day Trading, Closes at $11.22

The price of Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed at $11.22 in the last session, up 4.08% from day before closing price of $10.78. In other words, the price has increased by $+0.44 from its previous closing price. On the day, 11162805 shares were traded. Ratios: We take a closer look at RXRX’s different ratios […]

Analysts provide stock recommendations for Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed the day trading at $12.30 down -3.98% from the previous closing price of $12.81. In other words, the price has decreased by -$0.51 from its previous closing price. On the day, 6823455 shares were traded. Ratios: For a better understanding of RXRX, let’s look at its different ratios. For […]

Recursion Pharmaceuticals Inc (RXRX)’s financial ratios: A comprehensive overview

After finishing at $15.52 in the prior trading day, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) closed at $12.94, down -16.62%. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 12944574 shares were traded. Ratios: Our goal is to gain a better understanding of RXRX by taking a closer […]

Recursion Pharmaceuticals Inc (RXRX) Shares See Highest Trading Level at $15.52

As of close of business last night, Recursion Pharmaceuticals Inc’s stock clocked out at $15.52, up 5.15% from its previous closing price of $14.76. In other words, the price has increased by $+0.76 from its previous closing price. On the day, 12479856 shares were traded. Ratios: To gain a deeper understanding of RXRX’s stock, we […]